These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3310016)

  • 1. Fendiline: a review of its basic pharmacological and clinical properties.
    Bayer R; Mannhold R
    Pharmatherapeutica; 1987; 5(2):103-36. PubMed ID: 3310016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic mechanisms underlying prenylamine-induced 'torsade de pointes': differences between prenylamine and fendiline due to basic actions of the isomers.
    Bayer R; Schwarzmaier J; Pernice R
    Curr Med Res Opin; 1988; 11(4):254-72. PubMed ID: 3063437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, randomized study of the anti-anginal and anti-ischaemic efficacy of fendiline and diltiazem in patients with coronary heart disease.
    Schulz J; Lubnau E; Grossmann M; Rück W
    Curr Med Res Opin; 1991; 12(8):521-39. PubMed ID: 1764956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study.
    Silber S; Vogler A; Theisen K
    Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological Properties of Fendiline in Cardiac and Smooth Muscle (author's transl)].
    Kukovetz WR; Pöch G; Holzmann S; Paietta E
    Arzneimittelforschung; 1976; 26(7):1321-30. PubMed ID: 1036917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH
    Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical activity of the ischaemic myocardium as affected by verapamil and fendiline.
    Hála O; Papp JG; Szekeres L
    Acta Physiol Hung; 1990; 75 Suppl():139-40. PubMed ID: 2371843
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of the mutagenicity of anticancer drugs by the calcium antagonists verapamil and fendiline.
    Scheid W; Weber J; Röttgers U; Traut H
    Arzneimittelforschung; 1991 Sep; 41(9):901-4. PubMed ID: 1796917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fendiline for hypodynamic coronary heart disease patients. Calmodulin antagonists--alternatives to calcium antagonism].
    Fortschr Med; 1985 Oct; 103(40):64. PubMed ID: 4065792
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of two calcium antagonists, verapamil and fendiline, in an experimental model of myocardial ischaemia mimicking classical angina on effort.
    Csik V; Szekeres L; Udvary E
    Br J Pharmacol; 1983 May; 79(1):37-43. PubMed ID: 6871551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of calcium antagonists.
    Fleckenstein A
    Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open state block by fendiline of L-type Ca++ channels in ventricular myocytes from rat heart.
    Nawrath H; Klein G; Rupp J; Wegener JW; Shainberg A
    J Pharmacol Exp Ther; 1998 May; 285(2):546-52. PubMed ID: 9580596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U; Blasini R; Rudolph W
    Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamics, cardiac conduction and pharmacokinetics of mibefradil (Ro 40-5967), a novel calcium antagonist.
    Petrie JR; Glen SK; MacMahon M; Crome R; Meredith PA; Elliott HL; Reid JL
    J Hypertens; 1995 Dec; 13(12 Pt 2):1842-6. PubMed ID: 8903664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)].
    Reiterer W
    Wien Med Wochenschr; 1980 Dec; 130(23):772-7. PubMed ID: 6111161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Sensit (fendiline) in the light of new data.
    Szám L; Tardos L
    Ther Hung; 1987; 35(1):19-22. PubMed ID: 3326203
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of verapamil and fendiline in the treatment of chronic coronary insufficiency. Clinical and ergometric evaluation].
    Candau LA; Pereira LS; Lavall MA; Carvalho CR
    Arq Bras Cardiol; 1982 Aug; 39(2):135-8. PubMed ID: 6763518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.